NCT03580252

Brief Summary

In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 19, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 9, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2019

Completed
Last Updated

January 28, 2019

Status Verified

January 1, 2019

Enrollment Period

11 months

First QC Date

April 19, 2018

Last Update Submit

January 25, 2019

Conditions

Keywords

pretermChild Development DisordersHammersmithneurological outcomesepidemiology

Outcome Measures

Primary Outcomes (1)

  • Non inferiority of MRI to Hammersmith assessments in developmental outcomes

    Hammersmith assessment will be tested for non-inferiority to gold standard assessment method by MRI in terms of sensitivity for early prediction of delayed neurological syndrome (DNS)

    12 month

Secondary Outcomes (5)

  • Superiority testing for Hammersmith assessment to gold standard MRI

    12 month

  • Comparing the correlations of MRI and US scans with early prediction of DNS

    12 month

  • Comparing the correlations of US scan and Hammersmith assessment

    12 month

  • Hammersmith health economic analyses if primary endpoint is achieved

    12 month

  • Specificity and sensitivity for all techniques MRI, US and Hammersmith

    12 month

Study Arms (1)

Preterm Infant Neurological Follow-Up

Preterm infants \<37 weeks' gestational age (GA) at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants \<37weeks at birth over a 1-year stating from march 2018. A Correlation analyses for the outcomes with initial regular medical practice of MRI/Ultrasound and Hammersmith assessment.

Other: Correlation analyses for the outcomes

Interventions

No medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound

Preterm Infant Neurological Follow-Up

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Preterm infants \<37 weeks' GA at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants \<37weeks at birth over a 1-year stating from march 2018

You may qualify if:

  • Preterm infants \<37 weeks' GA at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants \<37weeks at birth over a 1-year stating from march 2018

You may not qualify if:

  • infants with congenital or chromosomal abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abha Private Hospital

Abhā, 7415, Saudi Arabia

Location

MeSH Terms

Conditions

Developmental DisabilitiesPremature BirthCerebral Palsy

Condition Hierarchy (Ancestors)

Neurodevelopmental DisordersMental DisordersObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Mohamed Fleifel, MD MSc PhD

    College of Medicine, Mansoura University

    STUDY CHAIR
  • Rawya Abdelghani, MD MSc PhD

    College of Medicine, Al Azhar University

    STUDY DIRECTOR
  • Mohamed Ameen, MICR RPh

    IQVIA Switzerland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 19, 2018

First Posted

July 9, 2018

Study Start

March 1, 2018

Primary Completion

January 25, 2019

Study Completion

January 25, 2019

Last Updated

January 28, 2019

Record last verified: 2019-01

Locations